Andrew Hull
Presidente presso INMED PHARMACEUTICALS INC.
Patrimonio netto: 9 641 $ in data 30/04/2024
Posizioni attive di Andrew Hull
Società | Posizione | Inizio | Fine |
---|---|---|---|
INMED PHARMACEUTICALS INC. | Independent Dir/Board Member | 12/09/2016 | - |
Presidente | - | - | |
Direttore/Membro del Consiglio | 12/09/2016 | - |
Storia della carriera di Andrew Hull
Precedenti posizioni note di Andrew Hull
Società | Posizione | Inizio | Fine |
---|---|---|---|
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 01/03/2019 | 01/03/2020 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/06/2008 | 01/04/2018 |
Kenyon College | Direttore/Membro del Consiglio | - | - |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Direttore/Membro del Consiglio | 01/01/2009 | - |
Presidente | - | - |
Formazione di Andrew Hull
Kenyon College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Canada | 3 |
Posizioni
Director/Board Member | 4 |
Chairman | 2 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
INMED PHARMACEUTICALS INC. | Health Technology |
Aziende private | 3 |
---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Commercial Services |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Andrew Hull
- Esperienza